Cellular energy-buffering compound · Fact sheet

Creatine

Also known as creatine monohydrate · methylguanidineacetic acid

Creatine is not an FDA-approved drug for sarcopenia, cognitive decline, or aging. Human evidence supports some exercise and muscle outcomes, especially with resistance training, while cognitive effects are smaller, heterogeneous, and need better trials in clinical populations.

Not FDA approvedModerate human evidence

What is Creatine?

Creatine is made by the body, obtained from some foods, and stored largely in muscle as phosphocreatine to help regenerate cellular energy.

Creatine monohydrate is the best-studied supplemental form; results from it should not automatically be assigned to every creatine variant or multi-ingredient product.

Benefits & claims

Unlike many frontier compounds, creatine has a large randomized exercise literature and reproducible effects in some muscle settings.

Brain-energy biology has prompted trials in memory, sleep loss, depression, and aging, but the cognitive evidence is smaller and more variable.

What the evidence supports

  • Across randomized exercise trials, creatine often adds modest lean-mass and strength gains to resistance training.
  • Cognitive meta-analyses report possible memory benefits, especially in older groups, but confidence is limited by small and heterogeneous studies.
Research areas
  • Strength and lean mass
  • Exercise performance
  • Memory and cognition
  • Age-related muscle and brain energy

Dosage & frequency

Human study context

Creatine monohydrate has substantial human supplementation research, particularly alongside resistance exercise. There is no FDA-approved anti-aging drug regimen.

Randomized creatine monohydrate safety study

Fourteen football players during football-specific training

Amount
15 g/day for seven days, then 3 g/day for 49 days
Frequency
Daily during the study
Route studied or labeled
Oral

A specific study exposure, not a universal loading requirement or longevity schedule.

How to read these amounts

An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.

Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences

Formulations, interactions & practical context

Formulation differences

  • Creatine monohydrate has more direct evidence than many alternative creatine forms.
  • Exercise-associated benefits do not establish an effect on every cognitive or aging outcome.

Interactions & precautions

  • The cited small athletic study is not a comprehensive medicine-interaction study; its renal-marker results cannot establish safety with every concomitant treatment.

What is still unresolved

  • A universal longevity amount or schedule has not been established.

Side effects & risks

  • Short- and medium-term studies generally report good tolerability in studied populations, but individual medical context and product composition matter.
  • Changes in body water and creatinine-related laboratory interpretation can complicate simple assumptions about weight or kidney measures.
  • Multi-ingredient performance products add risks that cannot be attributed to creatine alone.

This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.

Clinical research

Moderate human evidence

Meta-analyses of randomized trials support added lean-mass and strength gains when creatine accompanies resistance training in older adults. Cognitive evidence suggests possible memory effects but has substantial heterogeneity and limited high-quality older-adult trials.

Studies

Personal experiences

Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.

Explore 3 sourced accounts by reported effect.

Energy: reported experiences

Mixed account · personal report

More energy and strength, with stomach discomfort

Another author described feeling less tired and stronger at the gym, alongside stomach discomfort and occasional diarrhea.

Reported use in this account

Product
Creatine powder; exact formulation not stated
Amount
Around 5 grams
Frequency
Daily
Route
Not specified clearly
Duration
Not specified clearly

This recent product-specific experience does not establish a typical response or apply to every formulation.

Read the original account

Approval status

Creatine is marketed as a dietary supplement and is not an FDA-approved drug for muscle loss, cognition, aging, or disease treatment.

Supplement evidence, not FDA drug approval

Creatine has meaningful human supplement evidence for some training-related outcomes, but no FDA-approved drug use for sarcopenia, cognition, or aging.

Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.

Open questions

  • Whether creatine prevents cognitive decline or dementia
  • Which older or clinical populations receive meaningful cognitive benefit
  • Very long-term outcomes across people with diverse medical conditions
  • How much benefit is independent of resistance training and adequate nutrition

Summary

Creatine supports some training-related muscle outcomes. Cognitive protection and longer healthy lifespan remain unproven.

Sources

Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.

  1. pubmedMeta-analysis of creatine and resistance training in older adults

    Randomized-trial synthesis of lean mass and upper- and lower-body strength outcomes.

  2. pubmedRandomized trial in vulnerable older women

    Controlled study separating creatine, resistance training, and combined effects.

  3. pubmedMeta-analysis of creatine and memory trials

    Synthesis reporting a possible memory effect with substantial heterogeneity.

  4. pubmedSystematic review of creatine and cognition in older adults

    Review emphasizing the small number and variable quality of older-adult studies.

  5. fdaFDA: dietary supplements are not preapproved for effectiveness

    FDA explanation of the regulatory distinction between approved drugs and marketed dietary supplements.

  6. pubmedRandomized creatine monohydrate study in football players

    Primary source for the practical reference information.

  7. nihNIH Office of Dietary Supplements: exercise research

    Agency evidence summary distinguishes studied creatine exposures and exercise outcomes.

How we assess sources · Suggest a correction